KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Invested Capital (2016 - 2025)

Historic Invested Capital for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $64.2 billion.

  • Amgen's Invested Capital fell 547.52% to $64.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $64.2 billion, marking a year-over-year decrease of 547.52%. This contributed to the annual value of $66.0 billion for FY2024, which is 687.28% down from last year.
  • As of Q3 2025, Amgen's Invested Capital stood at $64.2 billion, which was down 547.52% from $63.6 billion recorded in Q2 2025.
  • Amgen's 5-year Invested Capital high stood at $70.8 billion for Q4 2023, and its period low was $37.8 billion during Q1 2022.
  • Over the past 5 years, Amgen's median Invested Capital value was $63.6 billion (recorded in 2025), while the average stood at $56.2 billion.
  • Its Invested Capital has fluctuated over the past 5 years, first crashed by 1003.47% in 2022, then skyrocketed by 7703.62% in 2023.
  • Quarter analysis of 5 years shows Amgen's Invested Capital stood at $40.0 billion in 2021, then grew by 6.49% to $42.6 billion in 2022, then skyrocketed by 66.28% to $70.8 billion in 2023, then decreased by 6.87% to $66.0 billion in 2024, then decreased by 2.68% to $64.2 billion in 2025.
  • Its last three reported values are $64.2 billion in Q3 2025, $63.6 billion for Q2 2025, and $63.6 billion during Q1 2025.